Table 2.
Author, Year | Quality Assessment Tool Used | Review Process | Risk of Bias | Concerns | |||
---|---|---|---|---|---|---|---|
SEC | ISS | DCSA | SF | ||||
Siokis et al., 2021 [37] |
Cochrane Collaboration tool | Meta-analysis performed using studies of unclear or high risk of bias | |||||
Chisini et al., 2018 [8] |
Cochrane Collaboration tool | Language restrictions | |||||
Delgado et al., 2021 [32] |
Cochrane Collaboration tool | Publication date restrictions | |||||
Dias et al., 2018 [30] |
Cochrane Collaboration tool | Inclusion criteria and outcomes not clearly mentioned, a meta-analysis performed using studies of high risk of bias | |||||
Frencken et al., 2021 [36] |
Criteria by De Amorim et al., 2017 | Search strategy not reproducible; inclusion criteria not clearly mentioned; outcomes not pre-defined; no details given on data collection and appraisal; no clear data synthesis; and risk of bias tool not validated | |||||
Innes et al., 2015 [29] |
Cochrane Collaboration Tool | — | |||||
Kilpatrick et al., 2007 [26] |
Criteria by Curzon and Toumba, 2006 | Restricted data search; language restrictions; risk of bias tool not validated; no evaluation of clinical and methodological heterogeneity; and limited data on data collection and synthesis | |||||
Mickenautsch et al., 2010 [33] |
Cochrane Collaboration tool | Language restrictions | |||||
Mickenautsch et al., 2011 [35] |
Based on the availability of evidence indicating successful prevention of selection and detection/performance bias from start to the end of each trial | Risk of bias tool not validated; meta-analysis performed using studies of unclear or high risk of bias | |||||
Pires et al., 2018 [31] |
Cochrane Collaboration Tool | Meta-analysis performed using studies of unclear or high risk of bias | |||||
Ruengrungsom et al., 2018 [27] |
Cochrane Collaboration Tool | Restricted search strategy and data search; language restrictions; no details given on data collection and appraisal; primary studies with clinical and methodological heterogeneity; a majority of studies with an unclear risk of bias; and no meta-analysis performed | |||||
Tedesco et al., 2017 [20] |
Cochrane Collaboration Tool | Meta-analysis performed using studies of unclear risk of bias; heterogeneity and publication bias of primary studies | |||||
Tedesco et al., 2018 [34] |
Cochrane Collaboration Tool | Meta-analysis performed using studies of unclear or high risk of bias | |||||
van’t Hof et al., 2006 [28] |
NR | Language restrictions; search strategy not reproducible; restricted data search; inclusion criteria not clearly mentioned; and risk of bias tool not reported |
Abbreviations: SEC: study eligibility criteria; ISS: identification and selection of studies; DCSA: data collection and study appraisal; SF: synthesis and findings. = Low risk of bias. = High risk of bias. = Unclear risk of bias.